Development of new interventions and treatment for schistosomiasis morbidity control. Australia has played a lead role in Parasitology research. It is vital to remain at the forefront in combating the human and livestock diseases that parasites cause. Vaccine assessment and the large scale analysis of patient tissues are vital to the biotechnology, agriculture and pharmaceutical industries with outcomes leading to innovative strategies for control. Politically there is value as it is altruistic ....Development of new interventions and treatment for schistosomiasis morbidity control. Australia has played a lead role in Parasitology research. It is vital to remain at the forefront in combating the human and livestock diseases that parasites cause. Vaccine assessment and the large scale analysis of patient tissues are vital to the biotechnology, agriculture and pharmaceutical industries with outcomes leading to innovative strategies for control. Politically there is value as it is altruistic to develop new tools, technologies and treatments for the Asia/Pacific region. Economically, Australia will have first pass at developing the intellectual property arising. As well, the therapies would be developed locally to the benefit of Australia's human therapeutics industry and bio-reagent manufacturers.Read moreRead less
Dissecting the shared genetic architecture of psychiatric and psychological traits with application to prediction of genetic risk. Identification of the early phase of psychiatric disorders is considered critical for early intervention which is the essence of prevention. At present, the main obstacle to targeted early intervention strategies in psychiatric disorders is the non-specific nature of early stage symptoms. Many psychiatric disorders present with symptoms of depressed mood and anxiety ....Dissecting the shared genetic architecture of psychiatric and psychological traits with application to prediction of genetic risk. Identification of the early phase of psychiatric disorders is considered critical for early intervention which is the essence of prevention. At present, the main obstacle to targeted early intervention strategies in psychiatric disorders is the non-specific nature of early stage symptoms. Many psychiatric disorders present with symptoms of depressed mood and anxiety in the early stages, yet best intervention treatments are dependent on the final (unknown) diagnosed disorder. Prediction of genetic risk is likely to make an important contribution for identification of individuals at risk of specific psychiatric disorders so that the best early intervention treatment can be administered. Read moreRead less